Growth Metrics

Regeneron Pharmaceuticals (REGN) Exchange Rate Effect (2023 - 2026)

Regeneron Pharmaceuticals (REGN) has disclosed Exchange Rate Effect for 4 consecutive years, with -$900000.0 as the latest value for Q1 2026.

  • For Q1 2026, Exchange Rate Effect fell 250.0% year-over-year to -$900000.0; the TTM value through Mar 2026 reached -$1.2 million, down 400.0%, while the annual FY2025 figure was $300000.0, 142.86% up from the prior year.
  • Exchange Rate Effect hit -$900000.0 in Q1 2026 for Regeneron Pharmaceuticals, down from -$300000.0 in the prior quarter.
  • Across five years, Exchange Rate Effect topped out at $800000.0 in Q3 2024 and bottomed at -$900000.0 in Q1 2026.
  • Average Exchange Rate Effect over 4 years is -$141666.7, with a median of -$300000.0 recorded in 2024.
  • On a YoY basis, Exchange Rate Effect climbed as much as 500.0% in 2024 and fell as far as 450.0% in 2024.
  • Regeneron Pharmaceuticals' Exchange Rate Effect stood at $200000.0 in 2023, then plummeted by 450.0% to -$700000.0 in 2024, then soared by 57.14% to -$300000.0 in 2025, then tumbled by 200.0% to -$900000.0 in 2026.
  • According to Business Quant data, Exchange Rate Effect over the past three periods came in at -$900000.0, -$300000.0, and -$400000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.